CSI Short-Dated
Short-Dated » CSI

Cardiovascular Systems, Inc. (CSI), now a part of Abbott, specialized in innovative solutions for the treatment of peripheral and coronary artery disease through its proprietary orbital atherectomy systems. CSI’s flagship technologies include the Diamondback 360® Peripheral Orbital Atherectomy System and the Diamondback 360® Coronary Orbital Atherectomy System, both designed to modify calcified plaque and improve vessel compliance prior to stent placement or balloon angioplasty.

These systems use a diamond-coated crown that orbits within the vessel, sanding away plaque while preserving healthy tissue and facilitating better device delivery. CSI’s focus on challenging arterial disease—particularly in heavily calcified lesions—made it a valuable addition to Abbott’s vascular portfolio following its acquisition in 2023, further expanding minimally invasive treatment options for complex cardiovascular cases.

Select a type:

Important Account Approval Information-Please Read

We do not sell to the general public. You must be an authorized reseller or licensed medical professional in order to purchase medical devices from Synergy Surgical™. We will verify and maintain a copy of your medical or business license. Please note if the license on file is an international license we will only ship to a Freight Forwarder or directly overseas on your behalf. If you place an order and we are unable to verify your resale or medical license, we will cancel your order. If your account is not already approved, a Customer Service Representative will be in touch once you place your order. Thank you for your business.